| |SEPTEMBER 20268546258How Biologics and Complex Therapies Are Reshaping CDMO StrategyHow Can India Pharma Bridge the Gap Between Innovation and AccessHow a Culture of Thanks Fuels Retention in HospitalsAkhil Ravi, CEO, Aurigene Pharmaceutical Services LimitedAurelien Breton, Managing Director, Servier IndiaDr. Shashank Teotia, CHRO, Paras HealthVIVID OUTLOOKAFTERWORDIndia's Hospitals Risk Falling into the U.S.-Style Fee-for-Service TrapViren Shetty, Executive Vice Chairman, Narayana Health 66Why India's Pharma Manufacturing Boom Needs More Women in Core Plant Operations5052604856----BIODIMENSION TECHNOLOGYNUVACLIN RESEARCHINVICTUS BIOCAREVIZE HEALTH & HYGIENETissue Engineering PlatformPharma Site Management ServicesNeutraceutical Formulation SolutionsPharmaceutical DistributorANALYSISPHARMA SERVICES & SOLUTIONS STARTUPSREVITALIZING STARTUPS ECOSYSTEM IN INDIA'S ADVANCING PHARMA REALM
< Page 7 | Page 9 >